Economic Evaluation of ASCOT-BPLA: Antihypertensive Treatment With an Amlodipine-Based Regimen Is Cost Effective Compared With an Atenolol-Based Regimen
Heart- United Kingdom
doi 10.1136/hrt.2007.127217
Full Text
Abstract
Available in
Date
February 1, 2008
Authors
Publisher
BMJ